MANILA, Philippines — A flood control structure worth more than P87 million in Surigao del Norte collapsed just three years after it finished construction, even without consistent rainfall and strong ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Interesting Engineering on MSN
3D magnetic field ‘breakthrough’ for nuclear fusion plasma control wins coveted US award
Three PPPL researchers have earned the prestigious Kaul Foundation Prize for their groundbreaking work in fusion stability.
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
AZ Animals US on MSN
Huge Packs of Coyotes Thrive Across These States
Once thought of as solitary hunters, coyotes have revealed themselves to be far more social than many people realize. Across specific portions of the United States, clever coyotes are forming ...
TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...
Apple, Google, and Microsoft all offer free parental control apps or settings to help you keep your kids safer online. We walk you through the benefits and drawbacks of each. I review privacy tools ...
Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback